Cesca Therapeutics Inc. announced that Dr. Xiaochun Xu has been appointed to the company's board of directors. Dr. Xu is the Founder, Chairman and CEO of Boyalife Group. Since 2000 he served as a Project Leader at Pfizer, as a Director of Research at two publicly-traded companies and as a Vice President at Founder Group.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.579 USD | +4.23% | -6.46% | -3.66% |
1st Jan change | Capi. | |
---|---|---|
-3.66% | 4.6M | |
+4.67% | 7.73B | |
-6.58% | 4.59B | |
-4.41% | 2.99B | |
+9.05% | 2.21B | |
-30.84% | 1.05B | |
+12.49% | 1.05B | |
+4.32% | 914M | |
-49.44% | 800M | |
-18.94% | 722M |
- Stock Market
- Equities
- THMO Stock
- News ThermoGenesis Holdings, Inc.
- Cesca Therapeutics Inc. Appoints Xiaochun Xu to its Board of Directors